Ian M. Gould

12.2k total citations · 2 hit papers
87 papers, 4.7k citations indexed

About

Ian M. Gould is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Clinical Biochemistry. According to data from OpenAlex, Ian M. Gould has authored 87 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 36 papers in Applied Microbiology and Biotechnology and 31 papers in Clinical Biochemistry. Recurrent topics in Ian M. Gould's work include Antibiotic Use and Resistance (36 papers), Antimicrobial Resistance in Staphylococcus (31 papers) and Bacterial Identification and Susceptibility Testing (31 papers). Ian M. Gould is often cited by papers focused on Antibiotic Use and Resistance (36 papers), Antimicrobial Resistance in Staphylococcus (31 papers) and Bacterial Identification and Susceptibility Testing (31 papers). Ian M. Gould collaborates with scholars based in United Kingdom, Spain and United States. Ian M. Gould's co-authors include Peter Davey, Craig Ramsay, Erwin Brown, Esmita Charani, Abhijit M. Bal, Lynda Fenelon, Alison Holmes, Philip J Wiffen, Mark Wilcox and Claire Scott and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Cochrane Database of Systematic Reviews.

In The Last Decade

Ian M. Gould

86 papers receiving 4.6k citations

Hit Papers

Interventions to improve antibiotic prescribing practices... 2013 2026 2017 2021 2013 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian M. Gould United Kingdom 31 2.5k 1.4k 1.1k 1.0k 1.0k 87 4.7k
Benedikt Huttner Switzerland 37 2.2k 0.9× 875 0.6× 648 0.6× 1.4k 1.4× 681 0.7× 129 4.4k
Debra A. Goff United States 36 1.4k 0.6× 1.1k 0.8× 1.1k 1.0× 990 1.0× 479 0.5× 114 3.6k
W. Charles Huskins United States 32 2.4k 1.0× 1.8k 1.3× 1.2k 1.1× 2.1k 2.0× 945 0.9× 97 6.6k
Dilip Nathwani United Kingdom 48 2.8k 1.1× 2.4k 1.7× 1.3k 1.2× 2.8k 2.7× 1.0k 1.0× 209 8.2k
Sumanth Gandra United States 28 3.4k 1.4× 856 0.6× 555 0.5× 1.4k 1.4× 684 0.7× 80 7.5k
Inge C. Gyssens Netherlands 35 1.2k 0.5× 1.1k 0.8× 676 0.6× 1.0k 1.0× 438 0.4× 121 4.4k
C. Suetens Belgium 36 1.4k 0.5× 1.5k 1.1× 532 0.5× 1.5k 1.5× 639 0.6× 78 5.2k
Cliodna McNulty United Kingdom 40 2.0k 0.8× 783 0.6× 451 0.4× 1.5k 1.5× 1.4k 1.4× 211 5.7k
Marianne Billeter United States 9 2.1k 0.8× 2.2k 1.6× 1.7k 1.6× 1.3k 1.3× 625 0.6× 11 4.9k
I.M. Gould United Kingdom 32 1.2k 0.5× 1.0k 0.8× 679 0.6× 728 0.7× 380 0.4× 93 3.4k

Countries citing papers authored by Ian M. Gould

Since Specialization
Citations

This map shows the geographic impact of Ian M. Gould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Gould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Gould more than expected).

Fields of papers citing papers by Ian M. Gould

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Gould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Gould. The network helps show where Ian M. Gould may publish in the future.

Co-authorship network of co-authors of Ian M. Gould

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Gould. A scholar is included among the top collaborators of Ian M. Gould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Gould. Ian M. Gould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hijazi, Karolin, et al.. (2023). Chlorhexidine Resistance or Cross-Resistance, That Is the Question. Antibiotics. 12(5). 798–798. 31 indexed citations
2.
Aldeyab, Mamoon A., Stuart Bond, Ian M. Gould, et al.. (2023). Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach. Expert Review of Anti-infective Therapy. 21(10). 1125–1134.
3.
Conway, Barbara R., Faryal Khamis, Motasem Aldiab, et al.. (2022). Identifying Targets for Antibiotic Use for the Management of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in Hospitals—A Multi-Centre Nonlinear Time-Series Study. Antibiotics. 11(6). 775–775. 5 indexed citations
4.
Yusef, Dawood, Wail Hayajneh, Rami Y. Haddad, et al.. (2020). Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistantAcinetobacter baumannii(CRAb) in hospitals in Jordan. Journal of Antimicrobial Chemotherapy. 76(2). 516–523. 35 indexed citations
6.
Saeed, Kordo, Silvano Esposito, Ian M. Gould, et al.. (2018). Hot topics in necrotising skin and soft tissue infections. International Journal of Antimicrobial Agents. 52(1). 1–10. 20 indexed citations
7.
Milne, Kathleen, et al.. (2016). Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species. International Journal of Antimicrobial Agents. 48(5). 521–527. 13 indexed citations
8.
Hijazi, Karolin, et al.. (2016). Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections. International Journal of Antimicrobial Agents. 48(1). 86–90. 34 indexed citations
10.
Muszbek, N., Ruth Chapman, Chantelle Browne, et al.. (2013). Using Daptomycin in Hospitalised Patients with cSSTI Caused by <b><i>Staphylococcus aureus </i></b>Has an Impact on Costs. Chemotherapy. 59(6). 427–434. 1 indexed citations
11.
Davey, Peter, Erwin Brown, Esmita Charani, et al.. (2013). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Systematic Reviews. 2(4). CD003543–CD003543. 1313 indexed citations breakdown →
12.
Hara, Gabriel Levy, Ian M. Gould, Andrea Endimiani, et al.. (2013). Detection, treatment, and prevention of carbapenemase-producingEnterobacteriaceae: Recommendations from an International Working Group. Journal of Chemotherapy. 25(3). 129–140. 61 indexed citations
14.
Gould, Ian M.. (2010). Is vancomycin redundant for serious staphylococcal infection?. International Journal of Antimicrobial Agents. 36. S55–S57. 16 indexed citations
15.
Gould, Ian M.. (2009). Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect. International Journal of Antimicrobial Agents. 34. S8–S11. 28 indexed citations
16.
Gould, Ian M.. (2008). Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. International Journal of Antimicrobial Agents. 31. 1–9. 74 indexed citations
17.
Mackenzie, Fiona, Ian M. Gould, Julie Bruce, et al.. (2007). The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. Journal of Hospital Infection. 65. 73–81. 30 indexed citations
18.
Gould, Ian M., et al.. (2007). Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. International Journal of Antimicrobial Agents. 29(5). 536–543. 48 indexed citations
19.
Gould, Ian M.. (2002). The United Nations Report on Racism and Indigenous Australians.. Indigenous law bulletin. 5(16). 5. 3 indexed citations
20.
Gould, Ian M., et al.. (1980). The Use of Cerebrospinal Fluid Lactate Determination in the Diagnosis of Meningitis. Scandinavian Journal of Infectious Diseases. 12(3). 185–188. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026